scholarly article | Q13442814 |
P50 | author | Rossana Berardi | Q37378010 |
Roberto Labianca | Q39950156 | ||
Mario Scartozzi | Q42811548 | ||
P2093 | author name string | F Graziano | |
A Zaniboni | |||
S Cascinu | |||
A Sobrero | |||
S Barni | |||
G D Beretta | |||
G Gasparini | |||
V Catalano | |||
Italian Group for the Study of Digestive Tract Cancer | |||
P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 | ||
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer | Q28364999 | ||
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer | Q36114988 | ||
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial | Q39394495 | ||
Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line | Q41056508 | ||
Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study | Q44177866 | ||
P433 | issue | 2-3 | |
P921 | main subject | colorectal cancer | Q188874 |
fluorouracil | Q238512 | ||
irinotecan | Q412197 | ||
oxaliplatin | Q422327 | ||
P304 | page(s) | 212-216 | |
P577 | publication date | 2005-07-07 | |
P1433 | published in | Oncology | Q2016300 |
P1476 | title | The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients | |
P478 | volume | 68 |
Q44644471 | Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis |
Q46447739 | Healing of colonic anastomoses after immediate postoperative intraperitoneal administration of oxaliplatin |
Q43136067 | The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin |
Search more.